Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Remrise was a private consumer health and wellness company focused on sleep care through personalized, plant-powered supplement formulas. The company offered direct-to-consumer sleep products tailored using questionnaires and behavioral sleep data, combining herbs, adaptogens, amino acids, and sleep hygiene tools. Founded in 2018 and based in San Francisco, Remrise raised seed financing led by Founders Fund and was also described as having been fostered by Atomic. Available sources characterize the business as a sleep supplement and digital sleep-support brand rather than a biotech or pharmaceutical drug developer. Recent company-directory sources indicate the company is closed.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Remrise.